A States Assembly scrutiny report examined cultivation, processing, planning and security in the developing medicinal cannabis sector. It described separate low-THC, higher-THC and controlled-product licences, with responsibilities shared across regulators and ministers.[1]
Listed for context. No score change is recorded for Jersey here.
References
Checked. The date and the event were compared with a source that was read.